Imaging was the largest of GE HealthCare Technologies Inc.’s 4 reported lines in fiscal 2025, at $9.25B — 54% of $17.15B.
| Segment | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Imaging | $8.40B | $8.94B | $8.86B | $9.25B | |
| Ultrasound | — | — | — | — | |
| Avs | $2.69B | $2.67B | $2.71B | $2.75B | |
| Pdx | $1.96B | $2.31B | $2.51B | $2.90B | |
| Pcs | $2.09B | $2.28B | $2.19B | $2.26B | |
| Total | $15.13B | $16.20B | $16.27B | $17.15B |
In fiscal 2025, which ended December 31, 2025, the 4 segments GE HealthCare Technologies Inc. reported in this breakdown added up to $17.15B. That is less than the $20.63B in its breakdown by region, so these segments do not account for all of its revenue that year. Imaging was the largest segment, at $9.25B or 53.9% of the total, followed by Pdx ($2.90B, 16.9%) and Avs ($2.75B, 16.0%). Together, the two largest segments made up 70.8% of this total.
Compared with fiscal 2024, Pdx grew the fastest, rising 15.6% to $2.90B. Every sizeable segment reported in both years grew.
The table also keeps 1 segment that GE HealthCare Technologies Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 1 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2021 to 2025, as reported in GE HealthCare Technologies Inc.'s annual filings.
All Other Countries was the largest of GE HealthCare Technologies Inc.’s 3 reported lines in fiscal 2025, at $9.43B — 46% of $20.63B.
| Geography | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| All Other Countries | $8.20B | $8.76B | $8.92B | $9.43B | |
| United States | $7.82B | $8.23B | $8.62B | $9.17B | |
| China | $2.33B | $2.56B | $2.14B | $2.03B | |
| Total | $18.34B | $19.55B | $19.67B | $20.63B |
In fiscal 2025, which ended December 31, 2025, the 3 regions GE HealthCare Technologies Inc. reported in this breakdown added up to $20.63B. That was up 4.9% from $19.67B in fiscal 2024. All Other Countries was the largest region, at $9.43B or 45.7% of the total, followed by United States ($9.17B, 44.4%) and China ($2.03B, 9.8%). Together, the two largest regions made up 90.2% of this total.
Compared with fiscal 2024, United States grew the fastest, rising 6.4% to $9.17B. China fell the most, down 4.9% to $2.03B. Over fiscal 2022 to 2025, revenue across these regions went from $18.34B to $20.63B, a compound annual growth rate of 4.0%. All Other Countries' share of the total rose from 44.7% to 45.7% over the same years.
This breakdown covers every fiscal year from 2021 to 2025, as reported in GE HealthCare Technologies Inc.'s annual filings.
Product was the largest of GE HealthCare Technologies Inc.’s 2 reported lines in fiscal 2025, at $13.66B — 66% of $20.63B.
| Product and Service | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Product | $12.04B | $13.13B | $13.08B | $13.66B | |
| Products | — | — | — | — | |
| Service | $6.30B | $6.43B | $6.60B | $6.96B | |
| Services | — | — | — | — | |
| Total | $18.34B | $19.55B | $19.67B | $20.63B |
In fiscal 2025, which ended December 31, 2025, the 2 revenue lines GE HealthCare Technologies Inc. reported in this breakdown added up to $20.63B. That was up 4.8% from $19.67B in fiscal 2024. Product was the largest revenue line, at $13.66B or 66.2% of the total, followed by Service ($6.96B, 33.8%).
Compared with fiscal 2024, Service grew the fastest, rising 5.6% to $6.96B. Over fiscal 2022 to 2025, revenue across these revenue lines went from $18.34B to $20.63B, a compound annual growth rate of 4.0%. Product's share of the total rose from 65.7% to 66.2% over the same years.
The table also keeps 2 revenue lines that GE HealthCare Technologies Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 2 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2021 to 2025, as reported in GE HealthCare Technologies Inc.'s annual filings.
GE HealthCare Technologies Inc. (GEHC) breaks its revenue down by segment, region and revenue line. In fiscal 2025, its largest segment was Imaging, with $9.25B or 53.9% of the total, followed by Pdx at $2.90B (16.9%).
Imaging was GE HealthCare Technologies Inc.'s largest segment in fiscal 2025, with $9.25B in revenue, 53.9% of the $17.15B reported across its 4 segments.
All Other Countries was GE HealthCare Technologies Inc.'s largest region in fiscal 2025, with $9.43B in revenue, 45.7% of the $20.63B reported across its 3 regions.
Product was GE HealthCare Technologies Inc.'s largest revenue line in fiscal 2025, with $13.66B in revenue, 66.2% of the $20.63B reported across its 2 revenue lines.
Of the GE HealthCare Technologies Inc. segments reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, Pdx grew the fastest, rising 15.6% from $2.51B to $2.90B.
Every figure is taken from GE HealthCare Technologies Inc.'s annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by segment covers fiscal 2021 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.